4.6 Article

Grading of recommendations assessment, development, and evaluation concept article 5: addressing intransitivity in a network meta-analysis

期刊

JOURNAL OF CLINICAL EPIDEMIOLOGY
卷 160, 期 -, 页码 151-159

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jclinepi.2023.06.010

关键词

Network meta-analysis; Indirect evidence; Quality of evidence; Certainty of evidence; Intransitivity; GRADE

向作者/读者索取更多资源

This article discusses considerations for addressing intransitivity when assessing the certainty of evidence from network meta-analysis (NMA) using the GRADE approach. NMA authors should consider the credibility and strength of effect modification and the distribution of effect modifiers in direct comparisons when addressing intransitivity.
Objectives: This article describes considerations for addressing intransitivity when assessing the certainty of the evidence from network meta-analysis (NMA) using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. Intransitivity is induced by effect modification, that is, when the magnitude of the effect between an intervention and outcome differs depending on the level of another factor. Study Design and Setting: To develop this GRADE concept paper, the lead authors conducted iterative discussions, computer simulations, and presentations to the GRADE project group and at GRADE working group meetings. The GRADE Working Group formally approved the article in July 2022. Results: NMA authors can have a higher or a lower threshold to rate down the certainty of the evidence due to intransitivity, which depends on the extent of their concerns regarding the trustworthiness of indirect comparisons, and their view of the relative problems with rating down excessively or insufficiently. NMA authors should consider three main factors when addressing intransitivity: the credibility of effect modification, the strength of the effect modification, and the distribution of effect modifiers across the direct comparisons. To avoid double counting limitations of the evidence, authors should consider the relationship between intransitivity and other GRADE domains. Conclusion: NMA authors face theoretic and pragmatic challenges and in most situations need to assess intransitivity without the availability of empirical data. Thus, explicitness regarding perspective is crucial. (c) 2023 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, General & Internal

Good or best practice statements: proposal for the operationalisation and implementation of GRADE guidance

Omar Dewidar, Tamara Lotfi, Miranda W. Langendam, Elena Parmelli, Zuleika Saz Parkinson, Karla Solo, Derek K. Chu, Joseph L. Mathew, Elie A. Akl, Romina Brignardello-Petersen, Reem A. Mustafa, Lorenzo Moja, Alfonso Iorio, Yuan Chi, Carlos Canelo-Aybar, Tamara Kredo, Justine Karpusheff, Alexis F. Turgeon, Pablo Alonso-Coello, Wojtek Wiercioch, Annette Gerritsen, Miloslav Klugar, Maria Ximena Rojas, Peter Tugwell, Vivian Andrea Welch, Kevin Pottie, Zachary Munn, Robby Nieuwlaat, Nathan Ford, Adrienne Stevens, Joanne Khabsa, Zil Nasir, Grigorios Leontiadis, Joerg Meerpohl, Thomas Piggott, Amir Qaseem, Micayla Matthews, Holger J. Schunemann

Summary: An evidence-based approach is the gold standard for health decision-making, but the use of the GRADE approach for strong recommendations is inappropriate in cases where the evidence is indirect. We found widespread use of GPS in COVID-19 related recommendations, but guideline developers failed to transparently report their development process. We propose improvements to the operationalization of the GRADE guidance for GPS, including a structured process and standardized reporting.

BMJ EVIDENCE-BASED MEDICINE (2023)

Article Allergy

Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study

Bernardo Sousa-Pinto, Holger J. Schunemann, Ana Sa-Sousa, Rafael Jose Vieira, Rita Amaral, Josep M. Anto, Ludger Klimek, Wienczyslawa Czarlewski, Joaquim Mullol, Oliver Pfaar, Anna Bedbrook, Luisa Brussino, Violeta Kvedariene, Desiree E. Larenas-Linnemann, Yoshitaka Okamoto, Maria Teresa Ventura, Ioana Agache, Ignacio J. Ansotegui, Karl C. Bergmann, Sinthia Bosnic-Anticevich, G. Walter Canonica, Victoria Cardona, Pedro Carreiro-Martins, Thomas Casale, Lorenzo Cecchi, Tomas Chivato, Derek K. Chu, Cemal Cingi, Elisio M. Costa, Alvaro A. Cruz, Stefano Del Giacco, Philippe Devillier, Patrik Eklund, Wytske J. Fokkens, Bilun Gemicioglu, Tari Haahtela, Juan Carlos Ivancevich, Zhanat Ispayeva, Marek Jutel, Piotr Kuna, Igor Kaidashev, Musa Khaitov, Helga Kraxner, Daniel Laune, Brian Lipworth, Renaud Louis, Michael Makris, Riccardo Monti, Mario Morais-Almeida, Ralph Mosges, Marek Niedoszytko, Nikolaos G. Papadopoulos, Vincenzo Patella, Nhan Pham-Thi, Frederico S. Regateiro, Sietze Reitsma, Philip W. Rouadi, Boleslaw Samolinski, Aziz Sheikh, Milan Sova, Ana Todo-Bom, Luis Taborda-Barata, Sanna Toppila-Salmi, Joaquin Sastre, Ioanna Tsiligianni, Arunas Valiulis, Olivier Vandenplas, Dana Wallace, Susan Waserman, Arzu Yorgancioglu, Mihaela Zidarn, Torsten Zuberbier, Joao A. Fonseca, Jean Bousquet

Summary: This study analyzed data from MASK-air (R) to explore rhinitis control and treatment patterns over time. It identified 16 weekly patterns of rhinitis control and revealed common co-medication and medication change schemes in uncontrolled weeks, supporting the hypothesis that patients self-treat based on their symptoms.

ALLERGY (2023)

Article Medicine, Research & Experimental

Knowledge mobilization activities to support decision-making by youth, parents, and adults using a systematic and living map of evidence and recommendations on COVID-19: protocol for three randomized controlled trials and qualitative user-experience studies

Rana Charide, Lisa Stallwood, Matthew Munan, Shahab Sayfi, Lisa Hartling, Nancy J. Butcher, Martin Offringa, Sarah Elliott, Dawn P. Richards, Joseph L. Mathew, Elie A. Akl, Tamara Kredo, Lawrence Mbuagbaw, Ashley Motillal, Ami Baba, Matthew Prebeg, Jacqueline Relihan, Shannon D. Scott, Jozef Suvada, Maicon Falavigna, Miloslav Klugar, Tamara Lotfi, Adrienne Stevens, Kevin Pottie, Holger J. Schunemann

Summary: This study aims to evaluate and compare the public's understanding and preference for different presentations of COVID-19 health recommendations. The study will involve online surveys and virtual interviews. The findings will provide guidance for improving the delivery of health recommendations.

TRIALS (2023)

Article Allergy

Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air® approach

Jean Bousquet, Josep M. Anto, Bernardo Sousa-Pinto, Wienczyslawa Czarlewski, Anna Bedbrook, Tari Haahtela, Ludger Klimek, Oliver Pfaar, Piotr Kuna, Maciej Kupczyk, Frederico S. Regateiro, Boleslaw Samolinski, Arunas Valiulis, Arzu Yorgancioglu, Sylvie Arnavielhe, Xavier Basagana, Karl C. Bergmann, Sinthia Bosnic-Anticevich, Luisa Brussino, G. Walter Canonica, Victoria Cardona, Lorenzo Cecchi, Claudia Chaves-Loureiro, Elisio Costa, Alvaro A. Cruz, Bilun Gemicioglu, Wytske J. Fokkens, Juan Carlos Ivancevich, Helga Kraxner, Violeta Kvedariene, Desiree E. Larenas-Linnemann, Daniel Laune, Renaud Louis, Michael Makris, Marcus Maurer, Erik Melen, Yann Micheli, Mario Morais-Almeida, Joaquim Mullol, Marek Niedoszytko, Yoshitaka Okamoto, Nikolaos G. Papadopoulos, Vincenzo Patella, Nhan Pham-Thi, Philip W. Rouadi, Joaquin Sastre, Nicola Scichilone, Aziz Sheikh, Mikhail Sofiev, Luis Taborda-Barata, Sanna Toppila-Salmi, Ioanna Tsiligianni, Erkka Valovirta, Maria Teresa Ventura, Rafael Jose Vieira, Mihaela Zidarn, Rita Amaral, Ignacio J. Ansotegui, Annabelle Bedard, Samuel Benveniste, Michael Bewick, Carsten Bindslev-Jensen, Hubert Blain, Matteo Bonini, Rodolphe Bourret, Fulvio Braido, Pedro Carreiro-Martins, Denis Charpin, Ivan Cherrez-Ojeda, Tomas Chivato, Derek K. Chu, Cemal Cingi, Stefano Del Giacco, Frederic de Blay, Philippe Devillier, Govert De Vries, Maria Doulaptsi, Virginie Doyen, Gerard Dray, Jean-Francois Fontaine, R. Maximiliano Gomez, Jan Hagemann, Enrico Heffler, Maja Hofmann, Ewa Jassem, Marek Jutel, Thomas Keil, Vicky Kritikos, Inger Kull, Marek Kulus, Olga Lourenco, Eve Mathieu-Dupas, Enrica Menditto, Ralph Mosges, Ruth Murray, Rachel Nadif, Hugo Neffen, Stefania Nicola, Robyn O'Hehir, Heidi Olze, Yuliia Palamarchuk, Jean-Louis Pepin, Benoit Petre, Robert Picard, Constantinos Pitsios, Francesca Puggioni, Santiago Quirce, Filip Raciborski, Sietze Reitsma, Nicolas Roche, Monica Rodriguez-Gonzalez, Jan Romantowski, Ana Sa-Sousa, Faradiba S. Serpa, Marine Savoure, Mohamed H. Shamji, Milan Sova, Annette Sperl, Cristiana Stellato, Ana Todo-Bom, Peter Valentin Tomazic, Olivier Vandenplas, Michiel Van Eerd, Tuula Vasankari, Frederic Viart, Susan Waserman, Joao A. Fonseca, Torsten Zuberbier

Summary: MASK-air is a validated mHealth app that has enabled large-scale implementation studies in over 58,000 people with allergic rhinitis and/or asthma. It can address unmet patient needs in rhinitis and asthma care. MASK-air is recognized as a Good Practice by DG Sante and a candidate Good Practice by OECD.

CLINICAL AND TRANSLATIONAL ALLERGY (2023)

Review Pediatrics

Cancer risk with topical calcineurin inhibitors, pimecrolimus and tacrolimus, for atopic dermatitis: a systematic review and meta-analysis

Niveditha Devasenapathy, Alexandro Chu, Melanie Wong, Archita Srivastava, Renata Ceccacci, Clement Lin, Margaret MacDonald, Aaron Wen, Jeremy Steen, Mitchell Levine, Lonnie Pyne, Lynda Schneider, Derek K. Chu

Summary: This study systematically reviewed the risk of cancer in patients with atopic dermatitis using topical calcineurin inhibitors. The analysis of 110 studies found no significant association between the use of topical calcineurin inhibitors and cancer risk. These findings support the safe use of topical calcineurin inhibitors in the treatment of patients with atopic dermatitis.

LANCET CHILD & ADOLESCENT HEALTH (2023)

Editorial Material Medicine, General & Internal

Management of atopic dermatitis in infants

Anna Whalen-Browne, Hywel C. Williams, Derek K. Chu

CANADIAN MEDICAL ASSOCIATION JOURNAL (2023)

Review Allergy

Outcomes reported in randomized controlled trials for mixed and non-IgE-mediated food allergy: Systematic review

Manal Bel Imam, Charalampos-Vlasios Stikas, Payal Guha, Bo L. Chawes, Derek Chu, Matthew Greenhawt, Ekaterina Khaleva, Daniel Munblit, Nikita Nekliudov, Willem van de Veen, Ann-Marie M. Schoos

Summary: Background: Mixed and non-IgE-mediated food allergy can greatly impact the quality of life for patients and their families. This study aimed to assess the outcomes reported in clinical trials for these conditions, and found that the current reporting is inconsistent and lacks validation. It highlights the need for the development of core outcome measures to support effective treatments.

CLINICAL AND EXPERIMENTAL ALLERGY (2023)

Review Allergy

Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach

Matthew Greenhawt, Timothy E. Dribin, Elissa M. Abrams, Marcus Shaker, Derek K. Chu, David B. K. Golden, Cem Akin, Akterini Anagnostou, Faisal Almuhizi, Waleed Alqurashi, Peter Arkwright, James L. Baldwin, Aleena Banerji, Philippe Begin, Moshe Ben-Shoshan, Jonathan Bernstein, Theresa A. Bingemann, Carsten Bindslev-Jensen, Kim Blumenthal, Aideen Byrne, Julia Cahill, Scott Cameron, Dianne Campbell, Ronna Campbell, Michael Cavender, Edmond S. Chan, Sharon Chinthrajah, Pasquale Comberiati, Jacqueline J. Eastman, Anne K. Ellis, David M. Fleischer, Adam Fox, Pamela A. Frischmeyer-Guerrerio, Remi Gagnon, Lene H. Garvey, Mitchell H. Grayson, Ghislaine Annie Clarisse Isabwe, Nicholas Hartog, David Hendron, Caroline C. Horner, Johnathan O'B Hourihane, Edward Iglesia, Manstein Kan, Blanka Kaplan, Constance H. Katelaris, Harold Kim, John M. Kelso, David A. Khan, David Lang, Dennis Ledford, Michael Levin, Jay A. Lieberman, Richard Loh, Douglas P. Mack, Bruce Mazer, Ketan Mody, Gisele Mosnaim, Daniel Munblit, S. Shahzad Mustafa, Anil Nanda, Richard Nathan, John Oppenheimer, Iris M. Otani, Miguel Park, Ruby Pawankar, Kirsten P. Perrett, Jonny Peter, Elizabeth J. Phillips, Matthieu Picard, Mitchell Pitlick, Allison Ramsey, Trine Holm Rasmussen, Melinda M. Rathkopf, Hari Reddy, Kara Robertson, Pablo Rodriguez del Rio, Stephen Sample, Ajay Sheshadri, Javed Sheik, Sayantani B. Sindher, Jonathan M. Spergel, Cosby A. Stone, David Stukus, Mimi L. K. Tang, James M. Tracy, Paul J. Turner, Timothy K. Vander Leek, Dana V. Wallace, Julie Wang, Susan Wasserman, David Weldon, Anna R. Wolfson, Margitta Worm, Mona-Rita Yacoub

Summary: This guidance provides updates on immediate allergic reactions following COVID-19 vaccines, including recommendations for revaccinating individuals with first-dose allergic reactions and conducting allergy testing. The recommendations were formed by an international panel of experts and are based on recent meta-analyses and diagnostic accuracy studies.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Article Health Care Sciences & Services

The BIGG-REC database makes available all WHO/PAHO evidence informed recommendations

Martin Ragusaa, Fernando Tortosaa, Gabriel Radab, Camilo Vergarab, Leslie Zaragozaa, Jenee Farrella, Marcela Torresa, Veronica Abdalaa, Ariel Izcovicha, Michelle Habya, Holger J. Schunemannc, Sebastian Garcia-Saisoa, Ludovic Reveiza

Summary: This article describes the establishment and maintenance of a living database of recommendations developed by the PAHO/WHO using the GRADE assessment system. The database provides a valuable resource for health professionals and organizations to make evidence-informed decisions. It allows searching and filtering recommendations by various criteria.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2023)

Article Health Care Sciences & Services

GRADE guidance 36: updates to GRADE's approach to addressing inconsistency

Gordon Guyatt, Yunli Zhao, Martin Mayer, Matthias Briel, Reem Mustafa, Ariel Izcovich, Monica Hultcrantz, Alfonso Iorio, Ana Carolina Alba, Farid Foroutan, Xin Sun, Holger Schunemann, Hans DeBeer, Elie A. Akl, Robin Christensen, Stefan Schandelmaier

Summary: This study updates previous GRADE guidance by addressing inconsistencies and interpreting subgroup analyses through an iterative process of consultation with members of the GRADE working group.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2023)

Article Hematology

American Society of Hematology, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panamena de Hematologia, Sociedad Peruana de Hematologia, and SVH 2023 guidelines for diagnosis of venous thromboembolism and for its management in special populations in Latin America

Ignacio Neumann, Ariel Izcovich, Ricardo Aguilar, Guillermo Leon Basantes, Patricia Casais, Cecilia C. Colorio, Maria Cecilia Guillermo Esposito, Pedro P. Garcia Lazaro, Jaime Pereira, Luis A. Meillon Garcia, Suely Meireles Rezende, Juan Carlos Serrano, Mario L. Tejerina Valle, Diana Altuna, Pamela Zuniga, Felipe Vera, Lorena Karzulovic, Holger J. Schunemann

Summary: This study aims to provide evidence-based recommendations for the diagnosis and management of venous thromboembolism (VTE) in children and during pregnancy in Latin American settings. By collaborating with the American Society of Hematology (ASH) and local hematology societies, a guideline panel was formed and recommendations were adapted based on the Latin American context. This study emphasizes the importance of contextualizing guidelines in different settings to ensure feasibility and equity in healthcare.

BLOOD ADVANCES (2023)

Editorial Material Allergy

Next generation health guidelines: The role of real-life data in evidence-based medicine

G. Walter Canonica, Ioana Agache, Holger J. Schunemann, Nicolas Roche, David Price, Stefano del Giacco

ALLERGY (2023)

Review Medicine, General & Internal

Efficacy and Tolerability of Gefapixant for Treatment of Refractory or Unexplained Chronic CoughA Systematic Review and Dose-Response Meta-Analysis

Elena Kum, Matthew Patel, Nermin Diab, Mustafaa Wahab, Dena Zeraatkar, Derek K. Chu, Paul M. O'Byrne, Gordon H. Guyatt, Imran Satia

Summary: Gefapixant is a potential therapy for refractory or unexplained chronic cough. This study evaluated its efficacy and tolerability in adults with this condition. The findings suggest that Gefapixant can lead to modest improvements in cough frequency, severity, and quality of life, but it may also increase taste-related adverse events.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Pediatrics

Plain Language vs Standard Format for Youth Understanding of COVID-19 Recommendations A Randomized Clinical Trial

Lisa Stallwood, Adrian Sammy, Matthew Prebeg, Jacqueline Relihan, Ami Baba, Rana Charide, Shahab Sayfi, Sarah A. Elliott, Lisa Hartling, Matthew Munan, Dawn P. Richards, Joseph L. Mathew, Tamara Kredo, Lawrence Mbuagbaw, Ashley Motilall, Shannon D. Scott, Miloslav Klugar, Tamara Lotfi, Adrienne L. Stevens, Kevin Pottie, Holger J. Schuenemann, Nancy J. Butcher, Martin Offringa, RecMap Members

Summary: To ensure informed decision making by youths regarding their health, it is important to present health recommendations in a way that is easily understandable by youths.

JAMA PEDIATRICS (2023)

暂无数据